proline has been researched along with glycoprotein e2, hepatitis c virus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Falson, P; Lethias, C; Montigny, C; Penin, F | 1 |
Choi, DH; Han, KM; Hwang, SB; Lim, YS; Luong, TTD; Mai, HN; Nguyen, HC; Nguyen, LP; Park, C; Park, EM | 1 |
2 other study(ies) available for proline and glycoprotein e2, hepatitis c virus
Article | Year |
---|---|
Overcoming the toxicity of membrane peptide expression in bacteria by upstream insertion of Asp-Pro sequence.
Topics: Amino Acid Sequence; Aspartic Acid; Cell Fractionation; Cloning, Molecular; Escherichia coli; Glutathione Transferase; Membrane Proteins; Microscopy, Immunoelectron; Molecular Sequence Data; Mutagenesis, Insertional; Peptides; Proline; Recombinant Fusion Proteins; Serine Endopeptidases; Viral Envelope Proteins | 2004 |
5-Oxo-1-[(2,3,6,7-tetramethoxy-9-phenanthrenyl)methyl]-L-proline Inhibits Hepatitis C Virus Entry.
Topics: Alkaloids; Antiviral Agents; Cell Line, Tumor; Cell Survival; Drug Synergism; Drug Therapy, Combination; HEK293 Cells; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Indolizines; Interferon-alpha; Phenanthrenes; Primary Cell Culture; Proline; Sofosbuvir; Tetraspanin 28; Tylophora; Viral Envelope Proteins; Virus Internalization | 2019 |